Current clinical microbiology technologies are limited in breadth and design. With the rapid advances in next-generation sequencing (NGS) technologies, clinical and public health microbiology laboratories are increasingly adopting metagenomics into their existing laboratory workflows for infectious disease detection.
In this 3-part presentation, participants will learn about:
Lauge Farnaes, MD, PhD
Head of Medical Affairs
John W. A. Rossen, PhD, MSc
Head of Microbiology & Product Strategy, Europe
Robert Schlaberg, MD, PhD, MPH
Co-Founder, Chief Medical Officer